DR. FAROUK ANWARUL RAQUIB MD NPI 1477511194

NPI Details

DR. Farouk Anwarul Raquib, MD is a family medicine in Winfield, AL with 43 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Farouk Anwarul Raquib, MD NPI is 1477511194. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

125 BOB LAWRENCE DRIVE
WINFIELD, AL
ZIP 35594
Phone: (205) 487-4535

The NPI 1477511194 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• X-ray of chest, 2 views (HCPCS:71046)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Automated urinalysis test (HCPCS:81003)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Hemoglobin a1c level (HCPCS:83036)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) (HCPCS:80051)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood glucose (sugar) level (HCPCS:82947)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• X-ray of abdomen, 2 views (HCPCS:74019)
• Test for detection of infectious agent antibody, qualitative or semiquantitative (HCPCS:86318)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Vitamin d-3 level (HCPCS:82306)

The enumeration date for this NPI number is 5/2/2006 and was last updated on 6/24/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.